Management will present a corporate overview on Friday, March 28 th at 9:40 a.m. Eastern time, and will hold one-on-one meetings with registered investors and other attendees throughout the conference ...

In this article, we are going to take a look at where Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) stands against the other cheap stocks insiders are buying recently. Why should we be interested ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

Upgrade your Yahoo Finance plan to get complete details for Processa Pharmaceuticals, Inc. Get advanced tools and insights to navigate the markets.

Investing.com - Processa Pharmaceuticals (NASDAQ: PCSA) reported first quarter EPS of $-0.810, $0.49 worse than the analyst estimate of $-0.320. Revenue for the quarter came in at... ByInvesting ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.